Literature DB >> 14717986

A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia.

K Meijer, E B Haagsma, J van der Meer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14717986     DOI: 10.1111/j.1538-7836.2004.0562c.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  2 in total

1.  Hepatitis C viral infection in patients with hemophilia and hemolytic disorders.

Authors:  Eric S Orman; Michael W Fried
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-07-23

2.  Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial.

Authors:  A Chatterjee; M G Swain; S S Lee; V G Bain; K Peltekian; K Croitoru; P C Adams; K Kaita; J Teitel; E J Heathcote
Journal:  Can J Gastroenterol       Date:  2007-02       Impact factor: 3.522

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.